葫蘆娃(605199.SH):獲得骨化三醇軟膠囊藥品註冊證書
格隆匯2月28日丨葫蘆娃(605199.SH)公佈,近日收到國家藥品監督管理局覈準簽發的關於骨化三醇軟膠囊的《藥品註冊證書》。骨化三醇軟膠囊的適應症爲:1.絕經後骨質疏鬆;2.慢性腎功能衰竭,尤其是接受血液透析患者之腎性骨營養不良症;3.術後甲狀旁腺功能低下;4.特發性甲狀旁腺功能低下;5.假性甲狀旁腺功能低下;6.維生素 D 依賴性佝僂病;7.低血磷性維生素 D 抵抗型佝僂病等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.